FNB
CYCN icon

Farmers National Bank’s Cyclerion Therapeutics CYCN Stock Holding History

Farmers National Bank’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$1K Buy
+2
New +$566 ﹤0.01% 297

Other funds holding CYCN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Farmers National Bank's CYCN Position: Q2 2019 in Review

Farmers National Bank opened a new position in Cyclerion Therapeutics (CYCN) in Q2 2019: 2 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #297 among its holdings.

103 funds tracked by Wall St. Rank hold CYCN as of Q2 2019.

  • Farmers National Bank held 2 shares of Cyclerion Therapeutics worth $1K as of Q2 2019.
  • Cyclerion Therapeutics was a new Farmers National Bank position in Q2 2019.
  • Cyclerion Therapeutics made up ﹤0.01% of Farmers National Bank's portfolio in Q2 2019, its #297 holding.
  • 103 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2019.

Based on Farmers National Bank's 13F filing for Q2 2019, filed 22 Aug 2019.